Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform 2024-03-05 07:01
Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery 2024-03-05 06:55
Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024 2024-03-04 22:00
ACROBiosystems Launches New Initiative to Support Cell and Gene Manufacturers 2024-03-04 22:00
Optimum Nutrition Launches New Global Marketing Campaign "Unlock More You" 2024-03-04 22:00
Cyient Partners with MassMedic to Accelerate MedTech Innovation 2024-03-04 22:00
KCI, a subsidiary of Samyang Group, won 'Platinum Medal' in EcoVadis ESG Rating, Ranked in the Top 1% worldwide 2024-03-04 21:30
Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development 2024-03-04 21:19
Milliken & Company Recognized Among the 2024 World's Most Ethical Companies® 2024-03-04 21:00
Landmark Clinical Approval for YOLT-201 Obtained by the NMPA 2024-03-04 20:00
Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management 2024-03-04 20:00
Hybribio Calls for Raising International HPV Awareness 2024-03-04 18:47
Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting 2024-03-04 16:53
Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease 2024-03-04 16:22
THAILAND EXPECTS 25% GROWTH IN FITNESS AND MASS PARTICIPATION SPORTS FOR 2024 2024-03-04 09:00
Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease 2024-03-04 07:00
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2 2024-03-02 10:26
The 16th Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Development of TCM Takes Place in Nanyang, China 2024-03-02 05:10
LIFE FITNESS ANNOUNCES PROMOTION OF ANDREW MAHADEVAN TO CHIEF COMMERCIAL OFFICER TO LEAD CONTINUED GROWTH 2024-03-02 02:00
NMPA Approves the NDA for CARsgen's BCMA CAR-T Therapy Zevorcabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma 2024-03-01 21:50
1 27 28 29 30 31 1502